Every day Florida's population swells by more than 1,000 people, many of them retirees relocating for the second halves of their lives. There's little mystery why: Even in the coldest months of the year, the average daily high is at least 70 degrees, and the temperature rarely dips below 50 in th
With legal marijuana sales in North America expected to climb from $6.7 billion in 2016 to over $20 billion by 2020, the prices of some marijuana penny stocks will skyrocket right along with the 198% increase in sales.
Marijuana penny stocks are still speculative investments, and only some will see their share prices jump thanks to the industry’s growth. But we want to make sure....More>>>
Pipeline giant Kinder Morgan (NYSE:KMI) has been on the upswing in recent days after reporting better than expected Q3 2016 results. The company was able to hit most of the marks analysts were looking for, lowering debt and leverage as well as providing a crucial update to its capital return (dividends) plans.
Issued by state and local governments, municipal bonds yield an average of just 2.5%. But you wont owe a penny in federal tax on most types of muni-bond income, and you can get a break on state taxes, too, if you invest in munis issued in the state where you reside. For instance, if you live in a state with a stiff income tax, such as California, and are in the top combined federal and state....More>>>
Almost all the coverage you will find about Sunshine Capital Inc is press releases by Sunshine Capital Inc. Sunshine trades over the counter and is currently priced at $6.00 per share making it, in the view of my stick in the mud investor adviser, a “penny stock” too volatile for his firm to get involved with. A recent press release from Sunshine obliges me to clarify a piece I....More>>>
In this series, we look through the most recent Dividend Channel ”DividendRank” report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider’s view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and....More>>>
CBIS stock, or Cannabis Sciences Inc. (OTCMKTS: CBIS), is up another 13% today (Thursday) after it soared 30% Wednesday.
Based in Colorado Springs, Colo., Cannabis Sciences develops a wide range of cannabinoid-based pharmaceutical products. CBIS stock is running ahead of the multistate marijuana legalization vote on Nov. 8.
And this is just the most recent surge for Cannabis Sciences....More>>>
Welcome. In this article I will give the dollar and cents reasons for how come ERIC looks like a relative bargain in today’s marketplace.
In the trailing ten years ERIC has earned their market cap in free cash flow. This is a signal the company may be undervalued. If ERIC can repeat the performance and earn over $19B in the coming....More>>>
Succeeding 13 years of R&D with a commercial-level rare disease drug, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) tees up to deliver on the latter half of its promise to provide the world with a DMD cure for sufferers that may be amenable to Exon 51 skipping, and otherwise. A result that wo
Shares of Ignyta (NASDAQ:RXDX) have more than doubled over the past year, with news in May that the company received the coveted Breakthrough Therapy Designation for entrectinib providing momentum for the next leg up.
Shares of FibroGen (FGEN) have rocketed over 60% since my mid-July article focusing on the opportunity in Idiopathic Pulmonary Fibrosis, or IPF. I've now written on the stock three times since the beginning of the year, so it's probably more than obvious that I'm a fan.